Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
Document Type
Journal Article
Publication Date
3-1-2018
Journal
Obstetrics and gynecology
Volume
131
Issue
3
Inclusive Pages
431-439
DOI
10.1097/AOG.0000000000002462
Keywords
Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms
APA Citation
Simon, J., Catherino, W., Segars, J., Blakesley, R., Chan, A., Sniukiene, V., & Al-Hendy, A. (2018). Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.. Obstetrics and gynecology, 131 (3). http://dx.doi.org/10.1097/AOG.0000000000002462
Peer Reviewed
1
Open Access
1